Birchview Capital, LP

Name: Birchview Capital, LP: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in BURLINGTON, VT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1618205.

Share this page

Link

Story card, 1080 × 1920

Reported value$213.8m
Positions72

Holdings: 72 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 73 lines; lines for the same security and option type are added together here.

Birchview Capital, LP, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Change on the quarter before
KLA CorporationKLAC	COM NEW	482480100	53.8	25.2%	178,471	Added+158,588
Bristol-Myers Squibb CoBMY	COM	110122108	17.1	8.0%	297,243	Reduced−9,025
LAM Research CorporationLRCX	COM NEW	512807306	15.2	7.1%	35,000	Reduced−1,000
Intellia Therapeutics IncNTLA	COM	45826J105	6.8	3.2%	385,900	Reduced−59,500
Solid Biosciences IncSLDB	COM NEW	83422E204	6.7	3.1%	666,196	Added+40,216
Biodesix Inc	COM	09075X108	6.5	3.0%	286,804	Unchanged
Stoke Therapeutics IncSTOK	COM	86150R107	5.8	2.7%	178,110	Reduced−31,890
Ovintiv IncOVV	COM	69047Q102	5.7	2.6%	107,500	Unchanged
Nektar TherapeuticsNKTR	COM	640268306	5.7	2.6%	81,000	Added+50,000
Corcept Therapeutics IncCORT	COM	218352102	5.0	2.3%	57,200	Added+10,000
Neurocrine Biosciences IncNBIX	COM	64125C109	4.6	2.1%	27,190	Unchanged
Prothena Corp plc	SHS	G72800108	4.4	2.1%	449,019	Unchanged
Acadia Pharmaceuticals IncACAD	COM	004225108	4.3	2.0%	171,000	Unchanged
Protagonist Therapeutics IncPTGX	COM	74366E102	4.3	2.0%	35,018	Added+18
Compass Therapeutics IncCMPX	COM	20454B104	3.7	1.7%	1,675,000	Added+209,133
Relmada Therapeutics IncRLMD	COM	75955J402	2.8	1.3%	408,100	Reduced−1,287
Alkermes plc	SHS	G01767105	2.6	1.2%	50,000	Unchanged
Halozyme Therapeutics IncHALO	COM	40637H109	2.6	1.2%	33,251	Added+23,151
Celldex Therapeutics IncCLDX	COM NEW	15117B202	2.6	1.2%	69,900	Reduced−195
Cytokinetics IncCYTK	COM	23282W605	2.6	1.2%	30,000	Unchanged
Olema Pharmaceuticals IncOLMA	COM	68062P106	2.5	1.2%	199,000	Reduced−20,000
Vera Therapeutics IncVERA	CL A	92337R101	2.5	1.2%	57,758	Added+13,758
United Therapeutics CorpUTHR	COM	91307C102	2.4	1.1%	4,506	Added+6
Zenas Biopharma IncZBIO	COM	98937L105	2.4	1.1%	93,601	Added+23,601
Uniqure NV	SHS	N90064101	2.3	1.1%	50,697	Reduced−50,000
Pacific Biosciences of California IncPACB	COM	69404D108	2.3	1.1%	1,350,000	Reduced−150,000
Abivax SAABVX	SPONSORED ADS	00370M103	2.3	1.1%	17,000	New+17,000
VIR Biotechnology IncVIR	COM	92764N102	2.2	1.0%	220,000	New+220,000
Biogen IncBIIB	COM	09062X103	1.9	0.9%	9,000	Added+4,000
EQT CorporationEQT	COM	26884L109	1.8	0.9%	34,619	Unchanged
Bioage Labs IncBIOA	COM	09077V100	1.7	0.8%	69,000	New+69,000
Travere Therapeutics IncTVTX	COM	89422G107	1.6	0.8%	29,000	Reduced−200
Quidelortho Corp	COM	74838J101	1.6	0.7%	89,377	Added+6,829
Axsome Therapeutics IncAXSM	COM	05464T104	1.5	0.7%	6,000	Unchanged
Foghorn Therapeutics IncFHTX	COM	344174107	1.4	0.6%	281,937	Added+207
Bicycle Therapeutics plcBCYC	SPONSORED ADS	088786108	1.3	0.6%	313,616	Reduced−149,983
Structure Therapeutics IncGPCR	SPONS ADR	86366E106	1.3	0.6%	24,000	Reduced−76,000
Xenon Pharmaceuticals IncXENE	COM	98420N105	1.3	0.6%	21,032	Added+32
Novo Nordisk A/SNVO	ADR	670100205	1.2	0.5%	24,000	New+24,000
Freeport-Mcmoran CL-BFCX	CL-B	35671D857	1.1	0.5%	18,035	Reduced−5
Immunome IncIMNM	COM	45257U108	1.1	0.5%	50,000	Unchanged
Pharvaris N V	COM	N69605108	1.0	0.5%	29,847	Unchanged
Harrow Health IncHROW	COM	415858109	1.0	0.5%	24,000	Unchanged
Adagene IncADAG	ADS	005329107	1.0	0.5%	240,000	New+240,000
Definium Therapeutics IncDFTX	COM SHS	24477V105	0.9	0.4%	20,000	New+20,000
Silence Therapeutics plcSLN	ADS	82686Q101	0.8	0.4%	71,218	New+71,218
Bridgebio Pharma IncBBIO	COM	10806X102	0.7	0.3%	8,741	Added+53
4D Molecular Therapeutics IncFDMT	COM	35104E100	0.6	0.3%	48,505	New+48,505
Urogen Pharma Ltd	COM	M96088105	0.6	0.3%	16,487	New+16,487
Phathom Pharmaceuticals IncPHAT	COM	71722W107	0.6	0.3%	55,000	Reduced−140,000
CAMP4 Therapeutics CorpCAMP	COM	13463J101	0.5	0.2%	120,000	New+120,000
Savara IncSVRA	COM	805111101	0.5	0.2%	80,000	New+80,000
Candel Therapeutics IncCADL	COM	137404109	0.5	0.2%	47,756	Reduced−12,244
Altimmune IncALT	COM NEW	02155H200	0.5	0.2%	152,681	New+152,681
Compass Pathways LtdCMPS	SPONSORED ADS	20451W101	0.4	0.2%	30,000	Reduced−345,000
Karyopharm Therapeutics Inc	COM	48576U106	0.4	0.2%	42,952	Reduced−41,000
Cullinan Therapeutics IncCGEM	COM	230031106	0.4	0.2%	20,000	Unchanged
Trinity Cap IncTRIN	COM	896442308	0.4	0.2%	20,000	Unchanged
Capricor Therapeutics IncCAPR	COM NEW	14070B309	0.3	0.2%	14,352	New+14,352
Castle Biosciences IncCSTL	COM	14843C105	0.3	0.1%	12,984	Added+84
Invivyd IncIVVD	COM	00534A102	0.3	0.1%	342,275	New+342,275
Grace Therapeutics IncGRCE	COM	00439U104	0.3	0.1%	120,000	Added+70,000
Kayne Anderson BDC IncKBDC	COM SHS	48662X105	0.3	0.1%	20,000	Unchanged
Voyager Therapeutics IncVYGR	COM	92915B106	0.3	0.1%	75,147	Added+229
Pulmonx CorpLUNG	COM	745848101	0.3	0.1%	200,543	Reduced−49,678
Ocular Therapeutix IncOCUL	COM	67576A100	0.2	<0.1%	20,655	Reduced−299,345
Kyntra Bio IncKYNB	COM NEW	31572Q881	0.2	<0.1%	22,566	Unchanged
Elutia IncELUT	COM	05479K106	0.2	<0.1%	165,094	Unchanged
Quoin Pharmaceuticals LtdQNRX	SPONSORED ADS	74907L409	0.1	<0.1%	20,000	Unchanged
Lipocine IncLPCN	COM NEW	53630X203	0.0	<0.1%	16,712	Reduced−95,074
Docgo IncDCGO	COM	256086109	0.0	<0.1%	39,062	Reduced−511
Gossamer Bio Inc	COM	38341P102	0.0	<0.1%	18,176	Unchanged

Sold out: 15 positions

Held at the end of the quarter before and not reported this quarter.

Birchview Capital, LP, positions sold out
Issuer	Class	CUSIP	Weight	Change on the quarter before
Apellis Pharmaceuticals Inc	COM	03753U106	0.0%	Sold out−14,000
Apogee Therapeutics Inc	COM	03770N101	0.0%	Sold out−9,000
Arcus Biosciences IncRCUS	COM	03969F109	0.0%	Sold out−25,889
Engene Holdings Inc	COM	29286M105	0.0%	Sold out−250,000
Ideaya Biosciences IncIDYA	COM	45166A102	0.0%	Sold out−16,860
Kalvista Pharmaceuticals Inc	COM	483497103	0.0%	Sold out−57,000
Novocure Ltd	ORD SHS	G6674U108	0.0%	Sold out−202,330
Outset Medical Inc	COM	690145107	0.0%	Sold out−98,882
Phreesia IncPHR	COM	71944F106	0.0%	Sold out−14,300
Regenxbio IncRGNX	COM	75901B107	0.0%	Sold out−66,270
Rocket Pharmaceuticals IncRCKT	COM	77313F106	0.0%	Sold out−127,025
Ultragenyx Pharmaceutical IncRARE	COM	90400D108	0.0%	Sold out−62,000
Verastem IncVSTM	COM NEW	92337C203	0.0%	Sold out−150,000
Viridian Therapeutics IncVRDN	COM	92790C104	0.0%	Sold out−20,100
Zentalis Pharmaceuticals IncZNTL	COM	98943L107	0.0%	Sold out−17,503

Source: SEC EDGAR, Form 13F-HR, accession 0001618205-26-000003 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.